vs
太平洋生物科学（ASMB）与EMPIRE PETROLEUM CORP（EP）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是EMPIRE PETROLEUM CORP的1.5倍（$10.8M vs $7.1M），太平洋生物科学净利率更高（-85.2% vs -835.1%，领先749.9%），太平洋生物科学同比增速更快（57.6% vs -30.0%）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
伊拉克石油公司，前身为土耳其石油公司，是一家石油企业，1925年至1961年间几乎垄断了伊拉克境内所有石油勘探与开采业务，由当时全球多家顶尖石油企业共同持股，公司总部设立于英国伦敦。
ASMB vs EP — 直观对比
营收规模更大
ASMB
是对方的1.5倍
$7.1M
营收增速更快
ASMB
高出87.6%
-30.0%
净利率更高
ASMB
高出749.9%
-835.1%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $7.1M |
| 净利润 | $-9.2M | $-59.0M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | -834.5% |
| 净利率 | -85.2% | -835.1% |
| 营收同比 | 57.6% | -30.0% |
| 净利润同比 | 4.3% | -1306.0% |
| 每股收益（稀释后） | $-0.72 | $-1.74 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBEP
| Q4 25 | — | $7.1M | ||
| Q3 25 | $10.8M | $9.4M | ||
| Q2 25 | $9.6M | $8.8M | ||
| Q1 25 | $9.4M | $9.0M | ||
| Q4 24 | $7.4M | $10.1M | ||
| Q3 24 | $6.8M | $11.4M | ||
| Q2 24 | $8.5M | $12.8M | ||
| Q1 24 | $5.8M | $9.4M |
净利润ASMBEP
| Q4 25 | — | $-59.0M | ||
| Q3 25 | $-9.2M | $-3.8M | ||
| Q2 25 | $-10.2M | $-5.1M | ||
| Q1 25 | $-8.8M | $-4.2M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | $-9.6M | $-3.6M | ||
| Q2 24 | $-11.2M | $-4.4M | ||
| Q1 24 | $-9.1M | $-4.0M |
营业利润率ASMBEP
| Q4 25 | — | -834.5% | ||
| Q3 25 | -100.9% | -37.8% | ||
| Q2 25 | -115.2% | -56.0% | ||
| Q1 25 | -105.5% | -43.9% | ||
| Q4 24 | — | -38.9% | ||
| Q3 24 | -160.1% | -30.0% | ||
| Q2 24 | -143.0% | -15.0% | ||
| Q1 24 | -185.5% | -46.8% |
净利率ASMBEP
| Q4 25 | — | -835.1% | ||
| Q3 25 | -85.2% | -40.9% | ||
| Q2 25 | -105.9% | -57.8% | ||
| Q1 25 | -93.6% | -46.9% | ||
| Q4 24 | — | -41.6% | ||
| Q3 24 | -140.4% | -32.0% | ||
| Q2 24 | -130.7% | -34.3% | ||
| Q1 24 | -156.9% | -42.3% |
每股收益（稀释后）ASMBEP
| Q4 25 | — | $-1.74 | ||
| Q3 25 | $-0.72 | $-0.11 | ||
| Q2 25 | $-1.33 | $-0.15 | ||
| Q1 25 | $-1.17 | $-0.12 | ||
| Q4 24 | — | $-0.12 | ||
| Q3 24 | $-1.51 | $-0.12 | ||
| Q2 24 | $-1.98 | $-0.15 | ||
| Q1 24 | $-1.66 | $-0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $1.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $-4.6M |
| 总资产 | $240.0M | $65.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBEP
| Q4 25 | — | $1.2M | ||
| Q3 25 | $22.5M | $4.6M | ||
| Q2 25 | $24.0M | $2.3M | ||
| Q1 25 | $23.4M | $1.1M | ||
| Q4 24 | $38.3M | $2.3M | ||
| Q3 24 | $28.5M | $3.1M | ||
| Q2 24 | $19.2M | $9.3M | ||
| Q1 24 | $18.7M | $3.5M |
总债务ASMBEP
| Q4 25 | — | — | ||
| Q3 25 | — | $15.2M | ||
| Q2 25 | — | $14.6M | ||
| Q1 25 | — | $11.6M | ||
| Q4 24 | — | $11.3M | ||
| Q3 24 | — | $8.5M | ||
| Q2 24 | — | $8.5M | ||
| Q1 24 | — | $8.5M |
股东权益ASMBEP
| Q4 25 | — | $-4.6M | ||
| Q3 25 | $182.7M | $53.7M | ||
| Q2 25 | $18.1M | $54.5M | ||
| Q1 25 | $27.1M | $59.1M | ||
| Q4 24 | $33.4M | $62.8M | ||
| Q3 24 | $26.0M | $56.5M | ||
| Q2 24 | $34.7M | $58.7M | ||
| Q1 24 | $32.6M | $31.7M |
总资产ASMBEP
| Q4 25 | — | $65.9M | ||
| Q3 25 | $240.0M | $123.0M | ||
| Q2 25 | $80.8M | $124.7M | ||
| Q1 25 | $99.0M | $123.7M | ||
| Q4 24 | $119.2M | $123.9M | ||
| Q3 24 | $100.3M | $121.2M | ||
| Q2 24 | $115.3M | $119.9M | ||
| Q1 24 | $119.9M | $100.1M |
负债/权益比ASMBEP
| Q4 25 | — | — | ||
| Q3 25 | — | 0.28× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $-2.8M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | — |
| 自由现金流率自由现金流/营收 | -140.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBEP
| Q4 25 | — | $-2.8M | ||
| Q3 25 | $-15.1M | $330.0K | ||
| Q2 25 | $-16.8M | $-3.1M | ||
| Q1 25 | $-23.4M | $1.6M | ||
| Q4 24 | $-51.1M | $-8.8M | ||
| Q3 24 | $-15.2M | $12.8M | ||
| Q2 24 | $-17.1M | $-1.8M | ||
| Q1 24 | $-18.4M | $3.9M |
自由现金流ASMBEP
| Q4 25 | — | — | ||
| Q3 25 | $-15.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-51.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-17.1M | — | ||
| Q1 24 | $-18.4M | — |
自由现金流率ASMBEP
| Q4 25 | — | — | ||
| Q3 25 | -140.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -695.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -200.6% | — | ||
| Q1 24 | -317.7% | — |
资本支出强度ASMBEP
| Q4 25 | — | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
